Form 4 holding
Director, 10%+ Owner
BriaCell Therapeutics Corp.
- Security class
- Common Shares
- Shares / value
- 2,542,935
- Estimated value
- $5,632,601
- Report date
- 14 May 2024
- Price
- $2.22
- Ownership
- By L5 Capital Inc.
Marc Lustig - Director, 10%+ Owner at BriaCell Therapeutics Corp.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- BCTX, BCTXL, BCTXZ on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Marc Lustig since 13 Sep 2025
Reported holdings for Marc Lustig in BriaCell Therapeutics Corp.
Form 4 holding
Director, 10%+ Owner
BriaCell Therapeutics Corp.
- Security class
- Common Stock Warrants
- Shares / value
- 902,935
- Estimated value
- Report date
- 14 May 2024
- Price
- Ownership
- By L5 Capital Inc.
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Marc Lustig in BriaCell Therapeutics Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.